Semble Raises £30m to Scale Connected Healthcare Platform

London-based Semble has secured £30 million in Series C funding to scale its connected healthcare platform, designed to streamline outpatient care amid Europe’s growing demand for integrated digital solutions. The round was led by Revaia, with new investor Partech joining existing backers Mercia Ventures and Octopus Ventures, bringing Semble’s total funding to nearly £57 million. Founded in 2018 by Christoph Lippuner and Mikael Landau, Semble’s platform consolidates fragmented healthcare systems into a single, interoperable EHR and practice management tool. It handles patient workflows—scheduling, billing, diagnostics, and lab results—while integrating with over 1,200 third-party systems like Stripe, Xero, and lab networks. Currently used by 16,000 professionals across 1,700 organizations, including Nuffield Health and Modality, the platform has processed data for over 10 million patients. The funding will advance AI-driven automation to reduce clinical administrative burdens and expand Semble’s reach into complex enterprise health systems. France is a priority, where the platform gained regulatory approval last year and is rapidly adopted by outpatient networks. With private healthcare expanding across Europe, Semble aims to replace outdated legacy systems with a scalable, flexible infrastructure. Existing investors increased their stakes, reflecting confidence in Semble’s mission to modernize healthcare operations. The company’s growth aligns with Europe’s shift toward private, self-paying healthcare, where digital efficiency is critical. By centralizing data and automating workflows, Semble positions itself as a key player in reshaping outpatient care delivery.